Market Cap 1.64B
Revenue (ttm) 612.62M
Net Income (ttm) 117.08M
EPS (ttm) N/A
PE Ratio 10.77
Forward PE 10.90
Profit Margin 19.11%
Debt to Equity Ratio 0.50
Volume 50,200
Avg Vol 136,550
Day's Range N/A - N/A
Shares Out 93.72M
Stochastic %K 41%
Beta 0.60
Analysts Hold
Price Target $19.67

Company Profile

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mob...

Industry: Education & Training Services
Sector: Consumer Defensive
Phone: 55 31 3515 7550
Address:
Alameda Oscar Niemeyer, No. 119, 15th floor Vila da Serra, Nova Lima, Brazil
JarvisFlow
JarvisFlow Jun. 12 at 1:19 PM
UBS has updated their rating for Afya ( $AFYA ) to Neutral with a price target of 19.5.
0 · Reply
Estimize
Estimize Jun. 3 at 12:03 PM
Wall St is expecting 0.35 EPS for $AFYA Q2 [Reporting 08/14 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize May. 9 at 12:09 AM
$AFYA reported - EPS and - revenue for Q1. http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_content=AFYA&utm_medium=
0 · Reply
Doozio
Doozio Apr. 25 at 10:26 PM
$AFYA wen only da 🐑 remain da 🧠 shall spread with its huckleberries.
0 · Reply
macroaxis
macroaxis Apr. 7 at 12:28 AM
$AFYA - Risk alert: Afya maximum pain price is slipping https://www.macroaxis.com/stock-options/AFYA/Afya?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
StradukInvestors
StradukInvestors Apr. 1 at 11:15 AM
BREAKOUT POSSIBLY TODAY $MLGO $AFYA $LARK
0 · Reply
DonCorleone77
DonCorleone77 Mar. 14 at 1:02 AM
$AFYA Afya sees FY25 revenue R$3.67B-R$3.77B Sees FY25 adjusted EBITDA R$1.62B-R$1.72B. Sees FY25 capital expenditures R$250M-R$290M. The company said, "These outstanding results enabled another year of guidance achievement and reflect Afya's consistent growth and operational excellence. This consistency added to another strong intake cycle, pave the foundation for our 2025 guidance: Net Revenue is expected to range between R$ 3,670 million and R$3,770 million, while Adjusted EBITDA is anticipated to be between R$1,620 million and R$1,720 million, excluding any acquisition that may be concluded after the issuance of the guidance. Once again, we are guiding another strong round ahead and proving AFYA's resilience and ability to keep delivering solid results with a high predictability."
0 · Reply
DonCorleone77
DonCorleone77 Mar. 14 at 1:02 AM
$AFYA Afya reports Q4 adjusted EPS R$2.10 vs. R$1.79 last year Reports Q4 revenue R$849.02M vs. R$729.87M last year. The company said, "We proudly present another year of strong operational and financial performance, reflecting the differentials of our business model and the successful execution of our strategy. We closed the year with significant growth in net revenue and adjusted EBITDA delivering the guidance for 2024. These results underscore the strength of our ecosystem, which integrates Medical Education and Medical Practice Solutions to support the entire physician journey, from undergraduate studies to professional practice."
0 · Reply
JarvisFlow
JarvisFlow Mar. 11 at 10:00 AM
Morgan Stanley has adjusted their stance on Afya ( $AFYA ), setting the rating to Underweight with a target price of 19 → 17.
0 · Reply
Estimize
Estimize Mar. 5 at 6:18 PM
Wall St is expecting 0.28 EPS for $AFYA Q4 [Reporting 03/13 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on AFYA
Afya Limited Continues To Grow, But Limits Are Also Evident

May 21, 2025, 2:00 AM EDT - 5 weeks ago

Afya Limited Continues To Grow, But Limits Are Also Evident


Afya Limited (AFYA) Q1 2025 Earnings Call Transcript

May 10, 2025, 7:53 AM EDT - 6 weeks ago

Afya Limited (AFYA) Q1 2025 Earnings Call Transcript


Afya Limited Announces First-Quarter 2025 Financial Results

May 8, 2025, 8:11 PM EDT - 6 weeks ago

Afya Limited Announces First-Quarter 2025 Financial Results


Afya Assumes a Voluntary Commitment to Free Health Consultations

Sep 23, 2024, 6:25 PM EDT - 9 months ago

Afya Assumes a Voluntary Commitment to Free Health Consultations


Afya Limited (AFYA) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 10:19 PM EDT - 11 months ago

Afya Limited (AFYA) Q2 2024 Earnings Call Transcript


Afya Limited Releases 2023 Sustainability Report

Jul 31, 2024, 6:32 PM EDT - 11 months ago

Afya Limited Releases 2023 Sustainability Report


Afya Announces Changes to Its Board of Directors

Jul 1, 2024, 9:35 AM EDT - 1 year ago

Afya Announces Changes to Its Board of Directors


Afya Limited (AFYA) Q1 2024 Earnings Call Transcript

May 13, 2024, 2:24 AM EDT - 1 year ago

Afya Limited (AFYA) Q1 2024 Earnings Call Transcript


Afya Limited Announces First-Quarter 2024 Financial Results

May 9, 2024, 6:15 PM EDT - 1 year ago

Afya Limited Announces First-Quarter 2024 Financial Results


AFYA: Mr Market Is Mistaken

Apr 29, 2024, 4:19 AM EDT - 1 year ago

AFYA: Mr Market Is Mistaken


Afya Is Performing Well And Is A Buy

Mar 19, 2024, 6:10 PM EDT - 1 year ago

Afya Is Performing Well And Is A Buy


Afya Limited (AFYA) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 10:33 PM EDT - 1 year ago

Afya Limited (AFYA) Q4 2023 Earnings Call Transcript


Afya Limited Announces Medical Seats Increase in FIP Guanambi

Jan 24, 2024, 4:28 PM EST - 1 year ago

Afya Limited Announces Medical Seats Increase in FIP Guanambi


Afya Limited (AFYA) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:36 AM EST - 1 year ago

Afya Limited (AFYA) Q3 2023 Earnings Call Transcript


Afya: Poised For Growth, But Likely Fairly Valued

Nov 7, 2023, 4:09 AM EST - 1 year ago

Afya: Poised For Growth, But Likely Fairly Valued


Afya Limited (AFYA) Q2 2023 Earnings Call Transcript

Aug 28, 2023, 8:36 PM EDT - 1 year ago

Afya Limited (AFYA) Q2 2023 Earnings Call Transcript


Afya: An Undiscovered Gem With High Return Potential

Jul 10, 2023, 5:33 AM EDT - 2 years ago

Afya: An Undiscovered Gem With High Return Potential


JarvisFlow
JarvisFlow Jun. 12 at 1:19 PM
UBS has updated their rating for Afya ( $AFYA ) to Neutral with a price target of 19.5.
0 · Reply
Estimize
Estimize Jun. 3 at 12:03 PM
Wall St is expecting 0.35 EPS for $AFYA Q2 [Reporting 08/14 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize May. 9 at 12:09 AM
$AFYA reported - EPS and - revenue for Q1. http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_content=AFYA&utm_medium=
0 · Reply
Doozio
Doozio Apr. 25 at 10:26 PM
$AFYA wen only da 🐑 remain da 🧠 shall spread with its huckleberries.
0 · Reply
macroaxis
macroaxis Apr. 7 at 12:28 AM
$AFYA - Risk alert: Afya maximum pain price is slipping https://www.macroaxis.com/stock-options/AFYA/Afya?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
StradukInvestors
StradukInvestors Apr. 1 at 11:15 AM
BREAKOUT POSSIBLY TODAY $MLGO $AFYA $LARK
0 · Reply
DonCorleone77
DonCorleone77 Mar. 14 at 1:02 AM
$AFYA Afya sees FY25 revenue R$3.67B-R$3.77B Sees FY25 adjusted EBITDA R$1.62B-R$1.72B. Sees FY25 capital expenditures R$250M-R$290M. The company said, "These outstanding results enabled another year of guidance achievement and reflect Afya's consistent growth and operational excellence. This consistency added to another strong intake cycle, pave the foundation for our 2025 guidance: Net Revenue is expected to range between R$ 3,670 million and R$3,770 million, while Adjusted EBITDA is anticipated to be between R$1,620 million and R$1,720 million, excluding any acquisition that may be concluded after the issuance of the guidance. Once again, we are guiding another strong round ahead and proving AFYA's resilience and ability to keep delivering solid results with a high predictability."
0 · Reply
DonCorleone77
DonCorleone77 Mar. 14 at 1:02 AM
$AFYA Afya reports Q4 adjusted EPS R$2.10 vs. R$1.79 last year Reports Q4 revenue R$849.02M vs. R$729.87M last year. The company said, "We proudly present another year of strong operational and financial performance, reflecting the differentials of our business model and the successful execution of our strategy. We closed the year with significant growth in net revenue and adjusted EBITDA delivering the guidance for 2024. These results underscore the strength of our ecosystem, which integrates Medical Education and Medical Practice Solutions to support the entire physician journey, from undergraduate studies to professional practice."
0 · Reply
JarvisFlow
JarvisFlow Mar. 11 at 10:00 AM
Morgan Stanley has adjusted their stance on Afya ( $AFYA ), setting the rating to Underweight with a target price of 19 → 17.
0 · Reply
Estimize
Estimize Mar. 5 at 6:18 PM
Wall St is expecting 0.28 EPS for $AFYA Q4 [Reporting 03/13 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Feb. 20 at 9:00 PM
Wall St is expecting 0.44 EPS for $AFYA Q1 [Reporting 05/21 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
0 · Reply
PenkeTrading
PenkeTrading Feb. 20 at 10:21 AM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Afya Ltd. Is that bullish or bearish? $AFYA #Afya #RsiOverbought #NASDAQ
0 · Reply
KCclean
KCclean Feb. 15 at 3:36 PM
$AFYA price broke March 24 downtrend
0 · Reply
crusaderf16
crusaderf16 Feb. 14 at 5:49 PM
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 4 at 5:54 AM
WATCHLIST DEC 04 2024 $AFYA Goldman Sachs Initiates Coverage On Afya with Sell Rating, Announces Price Target of $16 $INTC B of A Securities Reiterates Underperform on Intel, Maintains $21 Price Target $ULTA Piper Sandler Maintains Neutral on Ulta Beauty, Raises Price Target to $360 $WDC Western Digital shares are trading lower after Citigroup cut its price target on the stock from $87 to $85. $JPM Piper Sandler Maintains Overweight on JPMorgan Chase, Raises Price Target to $275
0 · Reply
MegaTrade22
MegaTrade22 Nov. 17 at 2:11 PM
https://youtube.com/watch?v=hxXP8gMocjE&si=v_s2p-RT9gOBKM5I “Top 5 stocks set to explode” High short interest plays… $XPON $AFYA $RILY $PLRZ $TNON Pick your poison! Which one are you in for this week?
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 23 at 6:50 AM
What insights do you have on $AFYA's decline? RSI: 46.2% 50-day MA: $16.93 200-day MA: $18.2
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 15 at 1:53 PM
Stay protected! Buy a PUT on $AFYA at 15.0p! RSI: 47.13% 50-day MA: $17.0 200-day MA: $18.35
0 · Reply
DJBigD
DJBigD Sep. 17 at 8:35 PM
$GCT got out, currently trading $AFYA. Really strong financials. Will get back into GCT when things look more stable.
0 · Reply
Stock_Titan
Stock_Titan Sep. 6 at 1:03 PM
$AFYA Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio https://www.stocktitan.net/news/AFYA/afya-limited-announces-mec-decision-on-medical-seats-reconsideration-ce35zzuq8obc.html
0 · Reply
StockInvest_us
StockInvest_us Sep. 6 at 9:37 AM
Signal alert: $AFYA - Oversold Trend Short (Undervalued) https://stockinvest.us/l/JIbYjvPEzs
0 · Reply